KIMBERLY MALEJKO: Open Payments
NPI 1245514637 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,779 in 87 payments from 20 companies in 2025. Trend: 2023 $1,601 · 2024 $1,934 · 2025 $1,779
Food & beverage: $1,779
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $310 |
| ABBVIE INC. | 13 | $249 |
| Amgen Inc. | 12 | $215 |
| Janssen Biotech, Inc. | 10 | $194 |
| AstraZeneca Pharmaceuticals LP | 9 | $194 |
| Novartis Pharmaceuticals Corporation | 4 | $113 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Invivyd Inc | 2 | $66 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
| Aurinia Pharma U.S., Inc. | 2 | $57 |
Products named: Bimzelx, TREMFYA, SAPHNELO, RINVOQ, COSENTYX, SKYRIZI, BENLYSTA, TAVNEOS.
Industry payments across GA — which companies pay providers there.
